期刊文献+

肝癌组织Survivin和p-Akt及ER表达及其临床意义分析 被引量:4

Clinical pathology significance of Survivin,p-Akt and estrogen receptor expression in hepatocellular carcinoma tissues
原文传递
导出
摘要 目的:研究原发性肝细胞癌组织和癌旁组织中存活素(Survivin)、磷酸化Akt(p-Akt)和雌激素受体(ER)表达及意义。方法:应用蛋白质印迹法检测52例原发性肝细胞癌和8例正常癌旁组织中Survivin、P-Akt和ER的表达。结果:肝细胞癌组织中Survivin和p-Akt表达明显高于癌旁组织,Survivin和p-Akt的表达与肝癌患者术后复发呈阳性相关(P<0.05),且两者之间的表达也呈阳性相关(r=0.736,P<0.01),而ER在两种组织中表达相仿,与肝癌患者术后复发无相关性,P>0.05。多因素分析结果显示,肿瘤转移、Survivin和p-Akt阳性表达可作为肝癌复发的风险因子。结论:Survivin和p-Akt与原发性肝癌的发生发展关系极为密切,Survivin和p-Akt高表达者预后差,可作为肝癌预后的预测因子。 OBJECTIVE: To investigate the expression of Survivin,phosphorylation of Akt(p-Akt) and estrogen receptor(ER) in hepatocellular carcinoma(HCC) tissues and the relationship between these factors and the prognosis of HCC patients.METHODS: The expression of Survivin,p-Akt and ER was detected by western blot assay in the resected liver specimens from 52 patients with HCC and 8 cases of adjavent normal tissues.RESULTS: The expression of Survivin and p-Akt was positively correlated to the tumor recurrence in HCC patients,respectively(P0.05),and the positive correlation was also observed between the expressions of Survivin and p-Akt(r=0.736,P0.01).No correlation was found between ER and the recurrence of HCC patients(P0.05).Significant differences of disease-free survival rates occurred among subgroups of patients according to the expressions of Survivin and p-Akt.Multivariate analysis revealed that tumor metastasis,positive expression of Survivin and p-AKt were independent risk factors for the recurrence of HCC.CONCLUSIONS: The expression of Survivin and p-AKt in the tissues of HCC closely related to the recurrence of HCC.Survivin and p-AKt may become valuable prognostic factors for HCC patients.
出处 《中华肿瘤防治杂志》 CAS 2011年第24期1929-1932,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 江苏省高校自然基金(28KJB310015) 江苏省科技厅自然基金(BK2009443)
关键词 肝肿瘤 存活素 AKT磷酸化 雌激素受体 复发 liver neoplasms Survivin p-Akt ER recurrence
  • 相关文献

参考文献3

二级参考文献52

  • 1[3]Poon RT,Ng IO,Fan ST,Lai EC,Lo CM,Liu CL,Wong J.Clinicopathologic features of long-term survivors and diseasefree survivors after resection of hepatocellular carcinoma:a study of a prospective cohort.J Clin Oncol 2001; 19:3037-3044
  • 2[4]Francavilla A,Polimeno L,DiLeo A,Barone M,Ove P,Coetzee M,Eagon P,Makowka L,Ambrosino G,Mazzaferro V.The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro.Hepatology 1989; 9:614-620
  • 3[5]Claviere C,Bronowicki JP,Hudziak H,Bigard MA,Gaucher P.Role of sex steroids and their receptors in the pathophysiology of hepatocellular carcinoma.Gastroenterol Clin Biol 1998; 22:73-86
  • 4[6]Villa E,Grottola A,Colantoni A,De Maria N,Buttafoco P,Ferretti I,Manenti F.Hepatocellular carcinoma:role of estrogen receptors in the liver.Ann N Y Acad Sci 2002; 963:37-45
  • 5[7]Eagon PK,Elm MS,Epley MJ,Shinozuka H,Rao KN.Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats.Gastroenterology 1996; 110:1199-1207
  • 6[8]Nagasue N,Yu L,Yukaya H,Kohno H,Nakamura T.Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma:impact on intrahepatic recurrence after hepatic resection.Br J Surg 1995;82:542-547
  • 7[9]Nagasue N,Kohno H,Yamanoi A,Kimoto T,Chang YC,Nakamura T.Progesterone receptor in hepatocellular carcinoma.Correlation with androgen and estrogen receptors.Cancer 1991; 67:2501-2505
  • 8[10]Jonas S,Bechstein WO,Heinze T,Kling N,Lobeck H,Tullius SG,Steinmueller T,Neuhaus P.Female sex hormone receptor status in advanced hepatocellular carcinoma and outcome after surgical resection.Surgery 1997; 121:456-461
  • 9[11]Ng IO,Ng M,Fan ST.Better survival in women with resected hepatocellular carcinoma is not related to tumor proliferation or expression of hormone receptors.Am J Gastroenterol 1997;92:1355-1358
  • 10[12]Barbare JC,Bouche O,Bonnetain F,Raoul JL,Rougier P,Abergel A,Boige V,Denis B,Bianchi A,Pariente A,Milan C,Bedenne L.Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.J Clin Oncol 2005; 23:4338-4346

共引文献13

同被引文献57

  • 1Alkner S’Bendahl PO,Grabau D, et al. AIB1 is a predictive fac-tor for tamoxifen response in premenopausal women [J]. AnnOncol,2010,21(2) :238-244.
  • 2Xu Y,Chen Q,Li W,et al. Overexpression of transcriptional co-activator AIB1 promotes hepatocellular carcinoma progression byenhancing cell proliferation and invasiveness [J]. Oncogenne?2010,29(23):3386-3397.
  • 3He LR,Zhao HY,Li BK,et al. Overexpression of AIB1 negative-ly affectes survival of surgically resected non-small-cell lungcancer patients[J]. Ann Oncol,2010,21(8) : 1675-1681.
  • 4Barnes DM,Meyer JS,Gonzalez JG,et al. Relationship betweenc-erbB-2 immunoreactivity and thymidine labeling index in breastcarcinoma in situ[J]. Breast Cancer Res Treat,1991,18(1) :11-17.
  • 5Saegusa M, Okayasu I. Changes in expression of estrogen recep-tors a and p in relation to progesterone receptor and pS2 status innormal and malignant endometrium[J]. Jpn J Cancer Res,2000,91(5):510-518.
  • 6Altieri DC. Survivin,cancer networks and pathway-directed drugdiscovery[J], Nat Rev Cancer,2008,8(1) :61-70.
  • 7Eustance AJ,Mahgoub T,Tryfonopoulos D, et al. Prospects fornon-immunological molecular therapeutics in melanoma [J]. JBUON,2010,15(1) ;9-18.
  • 8Hermann B,Susanne H, Andreas B, et al. Immunohistochemicalexpression of Surviving and [gamma]-H2AX in vulvar intraepi-thelial neoplasia and low-stage squamous cell carcinoma[J]. Int JGynecological Pathol,2011,30(6) :583-590.
  • 9Al-Joudi FS? Iskandar ZA, Hasnan J, et al. Expression of Sur-vivin and its clinicopathological correlations in invasive ductalcarcinoma of breast [J]. Singapore Med?2007 ,48(7) :607-614.
  • 10Li X, Dang X, Sun X. Expression of Survivin and VEGF-C inbreast cancer tissue and its relation to lymphatic metastasis [J].Oncol,2012,33(2) :178-182.

引证文献4

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部